Results 41 to 50 of about 180 (132)

The Efficacy of Losartan Treatment in Hypertensive Type 2 Diabetic Patients

Endocrinology Research and Practice, 2022
The aim of this study is to evaluate the effects of losartan on hypertension, glomerular hyperfiltration and urinary albumin excretion, and also assess the metabolic changes in comparison with ACEI. Thirty three type 2 diabetic hypertensive patients were
Akif Şahin, Halil Kavgacı, Halil Önder Ersöz, Cihangir Erem   +3 more
doaj   +2 more sources

Impact of Renin–Angiotensin–Aldosterone System (RAAS) Gene Polymorphism in Essential Hypertension and Antihypertensive Drug Therapy: A Review

International Journal of Hypertension, Volume 2025, Issue 1, 2025.
Genetic, demographic and environmental factors all play a role in the frequency of an intricate multifactorial condition known as hypertension. Approximately 30% and 50% of BP fluctuation are influenced by genetic variability. Many genetic studies have confirmed the link between genetic variability and susceptibility to essential hypertension; hence ...
Archana Adhikari, Chandrakala Sharma, Mingma Lhamu Sherpa, Gauthaman Karaunakran, Mona Dhakal, Anita Sharma, Nidhi Chaudhary   +6 more
wiley   +1 more source

Polypharmacy and Potential Drug–Drug Interactions in Patients With Atrial Fibrillation

Journal of Clinical Pharmacy and Therapeutics, Volume 2025, Issue 1, 2025.
What is Known and Objective: The use of multiple medications, or polypharmacy, is associated with an elevated risk of potential drug–drug interactions (pDDIs), consequently heightening the probability of adverse drug reactions. Currently, there is a dearth of data regarding pDDIs in Chinese patients with atrial fibrillation (AF) within real‐world ...
Ying Bai, Jianqi Wang, Guangyao Li, Zhen Zhou, Nicholas B. Norgard   +4 more
wiley   +1 more source

Rediscovery of the implication of albuminuria in heart failure: emerging classic index for cardiorenal interaction

ESC Heart Failure, Volume 11, Issue 6, Page 3470-3487, December 2024.
Abstract The development of new drugs and device therapies has led to remarkable advancements in heart failure (HF) treatment in the past couple of decades. However, it becomes increasingly evident that guideline‐directed medical therapy cannot be one‐size‐fits‐all across a wide range of ejection fractions (EFs) and various aetiologies.
Kyung‐Duk Min, Yuki Matsumoto, Masanori Asakura, Masaharu Ishihara   +3 more
wiley   +1 more source

Influence of asilsartan medoxomile on arterial hypertension variability in patients with arterial hypertension and chronic obstructive pulmonary disease

Лечащий Врач, 2021
We studied hypotensive effects, as well as short-term, daily and long-term variability of arterial pressure against the background of treatment with angiotensin-transforming ferment inhibitor and angiotensin-ferment blockers II in patients with arterial ...
N. Yu. Grigorieva, M. E. Koroleva
doaj  

Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure

ESC Heart Failure, Volume 11, Issue 6, Page 3862-3871, December 2024.
Abstract Aims Limited data are available that evaluate the efficacy of renin‐angiotensin system inhibitor (RASI) dose‐reduction in older adults with heart failure with reduced ejection fraction following a heart failure hospitalization. Methods and results We examined a 5% random sample of Medicare beneficiaries with prescription coverage who were ...
Parag Goyal, Ligong Chen, Jennifer D. Lau, Robert S. Rosenson, Emily B. Levitan   +4 more
wiley   +1 more source

Histological Study on the Possible Protective Effect of Probiotics versus Fosinopril in a Rat Model of Myocardial Infarction

The Egyptian Journal of Histology
Introduction: Myocardial infarction (MI) is major health issue implicated in high rates of mortality globally. Fosinopril is an angiotensin converting enzyme inhibitor (ACE-I) which is linked to ameliorating cardiovascular disorders.
seham AbdElhamid Mohamed elkalawy, Dina Mohamed Radwan, Shimaa Mohsen Emam, Manal Ali Abdel Mohsen   +3 more
doaj   +1 more source

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES

Кубанский научный медицинский вестник, 2017
Aim. The article discusses the evaluation of the effect of 3-month therapy of angiotensin-converting enzyme fosinopril and angiotensin II receptor antagonists valsartan on the clinical manifestations of CHF, hemodynamics and morphofunctional parameters ...
Z. V. BITAROVA, O. V. REMIZOV, Z. T. ASTAKHOVА   +2 more
doaj   +1 more source

Pilot trial of an electronic decision support to improve care for emergency department patients with acute heart failure

ESC Heart Failure, Volume 11, Issue 6, Page 4432-4436, December 2024.
Abstract Aims Emergency department (ED) providers play an important role in the management of patients with acute heart failure (AHF). We present findings from a pilot study of an electronic decision support that includes personalized risk estimates using the STRIDE‐HF risk tool and tailored recommendations for initiating guideline directed medical ...
Dana R. Sax, Dustin G. Mark, Jamal S. Rana, Jie Huang, Scott D. Casey, Robert P. Norris, Viliami Tillage, Mary E. Reed   +7 more
wiley   +1 more source

VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL

Рациональная фармакотерапия в кардиологии, 2016
Aim. To study the therapeutic equivalence of original and generic fosinopril in patients with arterial hypertension (HT) of 1-2 degrees, and to evaluate the cost effectiveness of original drug substitution with generic. Material and methods.
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova   +3 more
doaj   +1 more source